OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages
Yuhua Shi, Qian Lv, Mengjie Zheng, et al.
International Immunopharmacology (2021) Vol. 92, pp. 107358-107358
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

NLRP3 and pyroptosis blockers for treating inflammatory diseases
Rebecca C. Coll, Kate Schroder, Pablo Pelegrı́n
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 8, pp. 653-668
Open Access | Times Cited: 441

The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases
Hallie Blevins, Yiming Xu, Savannah Biby, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 270

The role of inflammasomes in human diseases and their potential as therapeutic targets
Jing Yao, Keenan Sterling, Zhe Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73

Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)
Xiaolu Zhang, Ziyu Wang, Yujia Zheng, et al.
International Journal of Molecular Medicine (2023) Vol. 51, Iss. 4
Open Access | Times Cited: 59

Involvement of inflammasomes in tumor microenvironment and tumor therapies
Ziqi Zhang, Xue Li, Yang Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 47

Acacetin inhibits inflammation by blocking MAPK/NF-κB pathways and NLRP3 inflammasome activation
Juan Bu, Yeledan Mahan, Shengnan Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 17

Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases
Meini Chen, Rong Rong, Xiaobo Xia
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 65

Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
Daniela Maria Tănase, Emilia Valasciuc, Evelina Maria Gosav, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8162-8162
Open Access | Times Cited: 27

Inhibitors of NLRP3 Inflammasome in Ischemic Heart Disease: Focus on Functional and Redox Aspects
Pasquale Pagliaro, Cláudia Penna
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1396-1396
Open Access | Times Cited: 26

Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options
Sara Bindoli, Chiara Baggio, Andrea Doria, et al.
Drugs (2024) Vol. 84, Iss. 3, pp. 257-274
Open Access | Times Cited: 9

NLRP3 inflammasome in neuroinflammation and central nervous system diseases
Wen Xu, Yi Huang, Rongbin Zhou
Cellular and Molecular Immunology (2025)
Open Access | Times Cited: 1

Research Progress on the Role of Pyroptosis in Myocardial Ischemia-Reperfusion Injury
Liu Yang, Jing Zhang, Deju Zhang, et al.
Cells (2022) Vol. 11, Iss. 20, pp. 3271-3271
Open Access | Times Cited: 38

The NLRP3 inflammasome: role in the pathobiology of chronic pain
Chen Chen, Maree T. Smith
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1589-1603
Open Access | Times Cited: 21

The role of NLRP3 inflammasome in sepsis: A potential therapeutic target
Wenfang He, Haiyun Dong, Chenfang Wu, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109697-109697
Closed Access | Times Cited: 17

The research progression of direct NLRP3 inhibitors to treat inflammatory disorders
Xiu Chen, Ping Zhang, Yu Zhang, et al.
Cellular Immunology (2024) Vol. 397-398, pp. 104810-104810
Closed Access | Times Cited: 8

Pyroptosis: A spoiler of peaceful coexistence between cells in degenerative bone and joint diseases
Zhichao Li, Wenxiang Cheng, Kuanhui Gao, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 7

The role of NLRP3 inflammasome in inflammation-related skeletal muscle atrophy
Yukun Liu, Dongfang Wang, Tianyu Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28

Molecular Characteristics of Cell Pyroptosis and Its Inhibitors: A Review of Activation, Regulation, and Inhibitors
Shaoqiang Wei, Min Feng, Shidong Zhang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16115-16115
Open Access | Times Cited: 27

The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications
Kai Ding, Chao Song, Heng-Jing Hu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 24

Can pyroptosis be a new target in rheumatoid arthritis treatment?
Dengqiang Wu, Yujie Li, Ranxing Xu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11

Inflammatory pathophysiological mechanisms implicated in postpartum depression
Jialei Zhu, Jing Jin, Jing Tang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19

USP14 promotes pyroptosis of human annulus fibrosus cells derived from patients with intervertebral disc degeneration through deubiquitination of NLRP3
Bao Hai, Tianli Mao, Chuanchao Du, et al.
Acta Biochimica et Biophysica Sinica (2022) Vol. 54, Iss. 11, pp. 1720-1730
Open Access | Times Cited: 17

SUMOylation regulates GSDMD stability and pyroptosis
Yuhua Shi, Xinyue Li, Weilv Xu, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114187-114187
Closed Access

Resolution of inflammation during rheumatoid arthritis
Xiaoou Ye, Dan Ren, Qingyuan Chen, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

Page 1 - Next Page

Scroll to top